It’s time to let scientists study whether LSD, marijuana and ecstasy can ease psychiatric disorders
Discovery of new psychiatric medication, whether for the treatment of depression, autism or schizophrenia, is at a virtual standstill. As just one example, the antidepressants on the market today are no more effective at reversing the mood disorder than those that first became available in the 1950s.
New thinking is desperately needed to aid the estimated 14 million American adults who suffer from severe mental illness. Innovation would likely accelerate if pharmacologists did not have to confront an antiquated legal framework that, in effect, declares off-limits a set of familiar compounds that could potentially serve as the chemical basis for entire new classes of drugs.
LSD, ecstasy (MDMA), psilocybin and marijuana have, for decades, been designated as drugs of abuse. But they had their origins in the medical pharmacopeia. Through the mid-1960s, more than 1,000 scientific publications chronicled the ways that LSD could be used as an aid to make psychotherapy more effective. Similarly, MDMA began to be used as a complement to talk therapy in the 1970s. Marijuana has logged thousands of years as a medicament for diseases and conditions ranging from malaria to rheumatism.
National laws and international conventions put a stop to all that. The Controlled Substances Act of 1970 declared that these drugs have “no currently accepted medical use” and classified them in the most stringently regulated category of controlled substances: Schedule I. The resulting restrictions create a de facto ban on their use in both laboratories and clinical trials, setting up a catch-22: these drugs are banned because they have no accepted medical use, but researchers cannot explore their therapeutic potential because they are banned. Three United Nations treaties extend similar restrictions to much of the rest of the world.
The decades-long research hiatus has taken its toll. Psychologists would like to know whether MDMA can help with intractable post-traumatic stress disorder, whether LSD or psilocybin can provide relief for cluster headaches or obsessive-compulsive disorder, and whether the particular docking receptors on brain cells that many psychedelics latch onto are critical sites for regulating conscious states that go awry in schizophrenia and depression.
The Latest on: Psychoactive Drug Research
via Google News
The Latest on: Psychoactive Drug Research
- CBD: everything you need to know about the multifaceted ingredienton May 18, 2022 at 7:57 am
However, new research has suggested it may be beneficial for a number of conditions including anxiety, depression, inflammation, sleep disorders, migraines, joint pain, fibromyalgia, and even some ...
- Benzodiazepine Drugs Market to Perceive Substantial Growth by the End 2026on May 18, 2022 at 1:45 am
Transparency Market Research (TMR) has published a new report titled, “Benzodiazepine Drugs Market – Global Industry Analysis, Size, Share, Growth, ...
- Changing Patterns of Abuse Make It Harder to Stay Drug-Freeon May 17, 2022 at 6:10 am
Although that legislation is not expected to be approved by the Senate, its passage by the House offers a vivid glimpse of this country’s changing attitudes toward that particular drug. Along with ...
- 6 Facts About CBD That You Might Not Knowon May 17, 2022 at 3:00 am
The Fresh Toast - If you already use CBD or are thinking of buying it from online retailers, it's better to know a thing or two before trying it. - CBD ...
- Psychotropic Compound Synthesized from Rainforest Treeon May 16, 2022 at 5:13 am
Scripps Research scientists report that they have developed a ... in screening experiments conducted through the National Institute of Mental Health Psychoactive Drug Screening Program. These screens ...
- Chemists synthesize psychotropic compound from rainforest treeon May 13, 2022 at 4:04 am
The bark of the Galbulimima belgraveana tree, found only in remote rainforests of Papua New Guinea and northern Australia, has long been used by indigenous people for both healing and ceremony. A tea ...
- F-tags study reveals common misuses of psychotropic drugs in LTCon May 13, 2022 at 12:56 am
A study of deficiency-of-care citations in nursing homes offers lessons on reducing over-reliance on psychotropics in residents with dementia, investigators say.
- Drug Developmenton May 11, 2022 at 5:00 pm
In the course of my teaching, consulting, and just talking about psychopharmacology, it has become clear to me that most practitioners do not have the vaguest idea where psychotropic drugs come from.
- Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-livedon May 6, 2022 at 10:08 am
While the substance is considered to be quite safe compared to other psychoactive drugs, possible adverse reactions include ... “Psychedelic use in the general public is increasing, amidst increasing ...
- Some Research-based Facts about Marijuanaon May 5, 2022 at 11:50 pm
With marijuana legalization spreading throughout the United States, there are still a lot of misconceptions about the drug. Some people think that marijuana is harmless, while others believe it is a ...
via Bing News